Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leukemia, Myeloid, Acute 18Breast Neoplasms 17Advanced Solid Tumors 16Advanced Solid Tumor 12Carcinoma, Non-Small-Cell Lung 10Myelodysplastic Syndromes 8Solid Tumor 6Recurrence 6Prostatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Uterine Cervical Neoplasms 5Triple Negative Breast Neoplasms 5Stomach Neoplasms 5Ovarian Neoplasms 5Carcinoma, Hepatocellular 5Small Cell Lung Carcinoma 4Myeloproliferative Disorders 4Multiple Myeloma 4Advanced Solid Tumour 4Advanced Malignant Solid Tumor 4Solid Tumors 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Biliary Tract Neoplasms 3Advanced Lung Cancer 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2

Interventions

Injections 2Midazolam 1Drug Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Advanced Malignancies × Injections × Clear all
NCT06038058 2025-12-30

A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

BioRay Pharmaceutical Co., Ltd.

Phase 1 Recruiting
164 enrolled

Advanced Malignancies

NCT06937957 2025-11-21

A Study of BR111 in Patients With Advanced Malignancies

BioRay Pharmaceutical Co., Ltd.

Phase 1 Recruiting
166 enrolled

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡